G. Volpini

发表

Therapeutic Vaccination against Helicobacter pylori in the Beagle Dog Experimental Model: Safety, Immunogenicity, and Efficacy

G. Rossi, D. Fortuna, R. Rappuoli, 2004, Infection and Immunity.

Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides

D. Maione, G. Mancuso, J. Telford, 2009, Proceedings of the National Academy of Sciences.

Two cross‐reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties

Sébastien Brier, Alessia Genovese, Susan Lea, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

P. van Damme, U. D'Oro, O. Finco, 2021, NPJ vaccines.

Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease.

I. Margarit, G. Grandi, D. Maione, 2006, The Journal of infectious diseases.

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens.

Manmohan J. Singh, M. Ugozzoli, J. Kazzaz, 2006, Vaccine.

Antibody‐dependent macrophage‐mediated activity against Helicobacter pylori in the absence of complement

R. Rappuoli, S. Nuti, G. Giudice, 2002, European journal of immunology.

Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.

L. Nencioni, R. Rappuoli, A. Podda, 1992, The Journal of pediatrics.

Computational modeling of microfluidic data provides high-throughput affinity estimates for monoclonal antibodies

D. Medini, O. Finco, P. Lo Surdo, 2021, Computational and structural biotechnology journal.

Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses

R. Rappuoli, O. Finco, Simona Tavarini, 2013, Proceedings of the National Academy of Sciences.

One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies.

R. Rappuoli, O. Finco, E. Montomoli, 2012, Vaccine.

Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.

L. Nencioni, A. Podda, A. Casadei, 1993, The Journal of pediatrics.

Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment

L. Nencioni, R. Rappuoli, S. Peppoloni, 1991, Infection and immunity.

[A phase-I clinical trial of a new antitetanus/antidiphtheria vaccine for adults].

G. Fara, L. Nencioni, R. Rappuoli, 1991, Annali di igiene : medicina preventiva e di comunita.

Properties of the B oligomer of pertussis toxin

R. Rappuoli, L. Nencioni, M. Pizza, 1991, Infection and immunity.

A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity.

D. Boraschi, A. Tagliabue, S. Censini, 1986, Journal of immunology.

Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule

L. Nencioni, M. Pizza, R. Rappuoli, 1992, Infection and immunity.

Genetic approaches to a vaccine for pertussis.

L. Nencioni, M. Pizza, R. Rappuoli, 1991, Advances in experimental medicine and biology.

One-step immunoaffinity purification of bioactive human recombinant IL-1 beta with a monoclonal antibody directed to a well-exposed domain of the protein.

C. Baldari, D. Boraschi, G. Volpini, 1989, Journal of immunological methods.

Differential activity of interleukin 1α and interleukin 1β in the stimulation of the immune response in vivo

P. Bossù, P. Ghezzi, L. Nencioni, 1990 .

Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.

P. Bossù, L. Nencioni, D. Boraschi, 1990, European journal of immunology.

Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa.

L. Nencioni, R. Rappuoli, A. Podda, 1991, Vaccine.

Invariant NKT cells sustain specific B cell responses and memory

R. Rappuoli, O. Finco, S. Nuti, 2007, Proceedings of the National Academy of Sciences.

Influence of the peptide insolubilization method on detection of anti-peptide antibodies in ELISA. Evaluation of nonspecific interactions.

D. Boraschi, G. Volpini, G. Antoni, 1989, Journal of immunoassay.

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.

S. Bertholet, D. Medini, O. Finco, 2022, Vaccine.

A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.

L. Nencioni, G. Scapigliati, D. Boraschi, 1989, Journal of immunology.

Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans.

D. Radzioch, A. Cossarizza, E. Lugli, 2005, FEMS immunology and medical microbiology.

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults

S. Bertholet, M. Pizza, O. Finco, 2017, Human vaccines & immunotherapeutics.

Interleukin 1 and its synthetic peptides as adjuvants for poorly immunogenic vaccines.

P. Bossù, L. Nencioni, A. Tagliabue, 1989, Advances in experimental medicine and biology.

Synthesis and Biological Activity of the Immunomodulatory Site of Interleukin 1

L. Nencioni, D. Boraschi, A. Tagliabue, 1987 .